Intellectual property news covering patents, trademarks, copyright, IP litigation, trade secrets, and the business of innovation rights.
The New York Times has issued a strict usage policy forbidding automated data mining, scraping, and the development of large language models using its content. The notice prohibits creating archived datasets for others and explicitly bans developing software or machine learning models using the newspaper's content.
Two publishers and a group of authors have filed three separate copyright infringement lawsuits against the companies behind the Grok AI model. The suits allege that books were pirated and used without permission for training purposes, marking another escalation in legal challenges facing artificial intelligence developers.
GSK and Moderna have settled their patent litigation concerning COVID-19 and RSV vaccines through cross-licenses with no financial exchange. The agreement resolves GSK's 2024 claims regarding lipid nanoparticle technology, while a separate suit against Pfizer and BioNTech continues.
A Delaware federal jury found Reed Semiconductor not liable for infringing two patents held by Monolithic Power Systems Inc. related to semiconductor technology. However, the jurors declined to invalidate the patent claims during the proceedings.
Colossal Biosciences filed a lawsuit in Texas federal court against former vice president James Kehler, alleging he stole trade secrets and shared confidential data with rival labs Neion Bio and Felix Pets. The suit claims Kehler transferred sensitive scientific information to personal devices before joining competitors focused on avian sciences and gene editing.
The Internet & Communications Policy (ICMP) contends that Australia should reject Big Tech's requests to rewrite copyright laws for AI training, arguing such changes constitute a landgrab. The commentary suggests focusing on enforcement rather than legislative exemptions, warning that proposed reforms could devastate the Australian creative industries.
The Federal Circuit examined whether Moderna qualifies as a government contractor entitled to a statutory shield against Arbutus' infringement claims regarding COVID-19 vaccines. Judges expressed skepticism about classifying Moderna's vaccine development efforts as being "for the government," potentially overturning a lower court ruling.
The New York Times contends its copyright lawsuit against OpenAI and Microsoft will reshape AI economics and publisher bargaining power. As the case nears a ruling, the article suggests the outcome could set precedents for compensation models, with the Times positioning itself as a leader for other publishers facing existential threats from unchecked AI scraping.
Ola Sars contends that the music industry is missing $1.4 billion annually by failing to address widespread commercial music licensing non-compliance among U.S. businesses. Citing data that nearly 80% of venues use unlicensed consumer streams, the article suggests this represents an immediate revenue opportunity distinct from AI or subscription growth strategies.
Ross Intelligence has petitioned the full Third Circuit Court to overturn a lower panel's decision denying fair use protection for its AI training. The company argues the previous ruling misapplied legal standards regarding the use of Thomson Reuters' Westlaw headnotes for artificial intelligence development.